- Home
- PLRX vs HKD Comparison
PLRX vs HKD Comparison
Compare PLRX & HKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- HKD
- Stock Information
- Founded
- PLRX 2015
- HKD 2003
- Country
- PLRX United States
- HKD France
- Employees
- PLRX N/A
- HKD N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- HKD Finance: Consumer Services
- Sector
- PLRX Health Care
- HKD Finance
- Exchange
- PLRX Nasdaq
- HKD Nasdaq
- Market Cap
- PLRX 84.7M
- HKD 656.8M
- IPO Year
- PLRX 2020
- HKD 2022
- Fundamental
- Price
- PLRX $1.20
- HKD $1.80
- Analyst Decision
- PLRX Hold
- HKD
- Analyst Count
- PLRX 10
- HKD 0
- Target Price
- PLRX $9.79
- HKD N/A
- AVG Volume (30 Days)
- PLRX 1.5M
- HKD 491.2K
- Earning Date
- PLRX 08-06-2025
- HKD 01-01-0001
- Dividend Yield
- PLRX N/A
- HKD N/A
- EPS Growth
- PLRX N/A
- HKD 9.93
- EPS
- PLRX N/A
- HKD 0.23
- Revenue
- PLRX N/A
- HKD $20,445,000.00
- Revenue This Year
- PLRX N/A
- HKD N/A
- Revenue Next Year
- PLRX N/A
- HKD N/A
- P/E Ratio
- PLRX N/A
- HKD $7.56
- Revenue Growth
- PLRX N/A
- HKD N/A
- 52 Week Low
- PLRX $1.10
- HKD $1.65
- 52 Week High
- PLRX $16.10
- HKD $5.80
- Technical
- Relative Strength Index (RSI)
- PLRX 34.60
- HKD 42.55
- Support Level
- PLRX $1.23
- HKD $1.70
- Resistance Level
- PLRX $1.43
- HKD $1.81
- Average True Range (ATR)
- PLRX 0.11
- HKD 0.08
- MACD
- PLRX -0.02
- HKD -0.00
- Stochastic Oscillator
- PLRX 8.33
- HKD 26.48
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About HKD AMTD Digital Inc. (every five of which represent two)
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment, hotel operations, hospitality and VIP services segment and media and entertainment services. The company generates maximum revenue by providing financial digital solutions through its insurance brokerage services and other digital solutions services. Geographically, the company generates maximum revenue from Hong Kong and Singapore.